"A study in healthy people to test how 2 different formulations of a combination treatment (vicadrostat and empagliflozin) are taken up in the body and how food influences the amount of the medicines in the blood"
This study is designed for healthy volunteers and focuses on a combination of two medicines, vicadrostat and empagliflozin. Researchers want to understand how these medicines are taken up by the body and how much of them reach the bloodstream when given in two different forms. A key part of the study is to see if eating food before or after taking the medication changes how the body absorbs them. This type of early-stage research is vital to understanding new treatments. By studying healthy people, scientists can carefully observe how the medicines behave without the effects of any illness, which helps them decide the best way to give these medicines in future studies for patients who might benefit from them.
At a glance
What is this study about?
Imagine a new type of medicine that could help people. Before it can be given to patients who are unwell, scientists need to understand exactly how it works in the body. This particular study is about a combination of two medicines, called vicadrostat and empagliflozin. They are looking at two slightly different ways these medicines are put together (we call these 'formulations') to see if one works better than the other.
The main goal is to find out how well these medicines are absorbed into your body and how much of them get into your blood. It's a bit like seeing how much fuel a car takes in and how much actually gets to the engine. They also want to understand if it makes a difference whether you take the medicine on an empty stomach or after you've eaten. This kind of information is really important because it helps doctors and scientists figure out the best way for people to take the medicine in the future.
Because this is an early study, it's being done with healthy volunteers. This is so researchers can get a clear picture of how the medicine behaves without any other health conditions adding confusion. The information gathered from healthy people helps to make sure that when the medicine is eventually given to patients who need it, it will be as effective and safe as possible.
Key takeaways
- This is an early-stage study for healthy volunteers.
- It aims to understand how two medicines are absorbed and how food affects this.
- Participation involves taking the study medicines and regular blood tests.
- Safety is a top priority, with close monitoring by medical staff.
- You won't get a direct health benefit, but you'll contribute to medical knowledge.
Who may be eligible?
This study is looking for healthy volunteers, meaning people who do not have any major ongoing health problems. You need to be at least 18 years old to take part; there is no upper age limit.
Both men and women are welcome to participate. Researchers will check your overall health carefully to make sure that taking part in the study would be safe for you. This often involves a medical check-up, blood tests, and a review of your medical history.
Remember, even if you meet these general criteria, there might be other specific health checks or conditions that mean you can't take part, as the safety of participants is always the top priority. This will all be discussed with you before you make any decisions.
- Are you generally healthy with no major ongoing medical conditions?
- Are you 18 years old or older?
- Are you a man or a woman?
- Are you able to attend regular clinic visits?
- Are you willing to have blood samples taken?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you decide to take part, you would receive the experimental combination treatment, vicadrostat and empagliflozin, in two different forms. You might be asked to take the medicine on an empty stomach some days and after a meal on others. You'll have regular visits to the clinic, which will involve giving blood samples so researchers can measure the levels of the medicines in your body. There will also be other health checks, like measuring your blood pressure and heart rate, to make sure you are doing well. The total time you'd be involved in the study, including all visits and any follow-up, would be explained to you in detail.
Potential risks and benefits
Locations (1)
- —Germany
Common questions
What does 'healthy volunteer' mean in this study?
It means the study is for people who generally don't have any serious health problems and aren't taking regular long-term medications.
What are vicadrostat and empagliflozin?
They are two experimental medicines that are being tested together. This study is helping researchers understand how they work in the body.
Why is food important for these medicines?
Researchers want to see if eating food changes how much of the medicines get into your blood, which helps determine the best way to take them.
Will I get paid for taking part?
Payment for participation in healthy volunteer studies can vary. This will be clearly explained to you by the research team if applicable.
What happens to my information?
Your personal information will be kept confidential and your privacy protected. The results from the study will be used for scientific research, without identifying you by name.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.